Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study.
[QUALITY OF LIFE IN CARERS OF PATIENTS WITH MULTIPLE SCLEROSIS TAKING A DISEASE-MODIFYING MEDICATION: A PILOT STUDY].
Immunotherapy-responsive Allodynia due to Distal Acquired Demyelinating Symmetric (DADS) Neuropathy.
Phenytoin for neuroprotection - Authors' reply.
Yerba mate (Ilex paraguariensis) inhibits lymphocyte activation in vitro.
Patient wins right to care at home.
Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in rats.
The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis.
Response to "Vitamin D status is negatively correlated with retinal nerve fiber layer thickness in relapsing-remitting MS patients without acute optic neuritis" by Knippenberg et al.
One-time intrathecal triamcinolone acetonide application alters the redox potential in cerebrospinal fluid of progressive multiple sclerosis patients: a pilot study.
AxonSeg: Open Source Software for Axon and Myelin Segmentation and Morphometric Analysis.
Myelination.
The electrophysiological response to immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
Immunotherapies for neurodegenerative diseases: current status and potential of plant-made biopharmaceuticals.
Similar impact of multiple sclerosis and migraine on sexual function in women : Is the multiple sclerosis impact scale questionnaire useful?
Employment, disability pension and income for children with parental multiple sclerosis.
Long-term outcome of changes in cognitive function of young rats after various/different doses of whole brain irradiation.
Effects of Pilates exercises on sensory interaction, postural control and fatigue in patients with multiple sclerosis.
Characterizing retinal structure injury in African-Americans with multiple sclerosis.
Seasonality of tweets related to multiple sclerosis.
PDCD1 PD-1.3 polymorphism and allergic bronchial asthma in Russian and Buryat patients.
Progressive Multifocal Leukoencephalopathy Localized in the Cerebellum and Brainstem Associated with Idiopathic CD4(+) T Lymphocytopenia.
Subgroup and sensitivity analyses of annualized relapse rate over 2 years in the ADVANCE trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis.
Dynamic impact of brief electrical nerve stimulation on the neural immune axis-polarization of macrophages toward a pro-repair phenotype in demyelinated peripheral nerve.
No evidence of disease activity in multiple sclerosis patients.
Pages
« first
‹ previous
…
763
764
765
766
767
768
769
770
771
…
next ›
last »